Gov. Chris Christie has signed Senate Republican Leader Tom Kean’s bipartisan “Higher Education Epinephrine Emergency Treatment Act” to make New Jersey’s college campuses safer for people with allergies.
“This common-sense law is to save lives and allow colleges in New Jersey to provide the same protections to their students and staff members who have allergies as can K-12 schools in this state,” said Kean (R-Union, Morris, Somerset). “With the proper foresight and training colleges and universities can ensure immediate care to the many people who are allergic to things such as bee stings or certain foods.”
Senator Kean’s bipartisan S2448 allows public and independent institutions of higher education in New Jersey to develop a policy for the emergency administration of epinephrine to a member of the campus community for anaphylaxis when a medical professional is not available. The new law provides immunity for a licensed campus medical professional, trained designee and prescribing physician for good faith acts of administering epinephrine medication, which is used to treat anaphylaxis.
Colleges and universities that develop such policies must designate an appropriately licensed physician, physician assistant, advanced practice nurse, or registered nurse to serve as the “licensed campus medical professional,” who will oversee the institution’s epinephrine administration and train designees in the administration of epinephrine via a pre-filled auto-injector mechanism. Eligible designees must be members of the campus community who are at least 18 years of age; have, or reasonably expect to have, responsibility for at least one other member of the campus community as a result of the designee’s occupational or volunteer status; and satisfactorily complete the training protocol administered by the licensed campus medical professional.